Lazarus Taxon, page-17

In a way I'm glad they didnt come out of suspension on that recent announcement. If they are able to raise another million dollars or more and at the same time provide an update with more concrete timelines regarding the carl zeiss product and perhaps report a few sales of the cellive, then the share price might even go up. If they were trading at present I think there would be very few buyers, lots of sellers and who knows what the share price would be?

the recent announcement gives room for some hope. Of course we don't know how close the zeiss product is to actual release and sales, but let's hope they (optiscan) do know. I'm sure there is a very good chance the nay-sayers are correct that it will be another flop and another delay, but you just never know, for all we know they might be just about there. the question then is whether the zeiss product will be the bonanza we think it will be.